Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +30.88%
#3 Cysic Cysic +23.33%
#4 Fabric Protocol Fabric Protocol +19.88%
#5 Nockchain Nockchain +19.24%
#6 Bedrock Bedrock +18.65%
#7 Victoria VR Victoria VR +17.20%
#8 Velvet Velvet +17.00%
#9 Fake World Assets Fake World Assets +16.33%
#10 Tutorial Tutorial +11.41%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.

AXIM
Rang in Aktien #37613
AXIM Biotechnologies, Inc. specializes in the creation and distribution of... AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Aktienkurs
$0.0046
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$1.57M
Veränderung (1 Tag)
-8.00%
Veränderung (1 Jahr)
-9.80%
Land
US
Handel AXIM Biotechnologies, Inc. (AXIM)

Kategorie

Healthcare
Preis AXIM mit Marktkapitalisierung von B
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
AXIM
$0.0046
Marktkapitalisierung von AXIM Biotechnologies, Inc.(AXIM)
Marktkapitalisierung: $1.57M
Mit Stand August 2026 hat AXIM Biotechnologies, Inc. eine Marktkapitalisierung von $1.57M. Das macht AXIM Biotechnologies, Inc. laut unseren Daten zum 37613th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von AXIM Biotechnologies, Inc. von 2014 bis 2026
AXIM im Vergleich zu den Top 5 der beliebtesten stocks
Preis für AXIM Vermögenswert B Marktkapitalisierung von B Ergebnisse
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
$16,012.80 $1.57M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +348,104,279.79%
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
$13,187.74 $1.57M
Apple Inc. Apple Inc.
AAPL
$4.490T +286,689,849.69%
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
$12,225.50 $1.57M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +265,771,592.29%
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
$10,797.87 $1.57M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +234,736,134.87%
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.
$8,320.99 $1.57M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +180,891,035.73%